264 related articles for article (PubMed ID: 24904967)
41. Synthesis and in vitro evaluation of hydrazinyl phthalazines against malaria parasite, Plasmodium falciparum.
Subramanian G; Babu Rajeev CP; Mohan CD; Sinha A; Chu TTT; Anusha S; Ximei H; Fuchs JE; Bender A; Rangappa KS; Chandramohanadas R; Basappa
Bioorg Med Chem Lett; 2016 Jul; 26(14):3300-3306. PubMed ID: 27261180
[TBL] [Abstract][Full Text] [Related]
42. Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells.
Marek L; Hamacher A; Hansen FK; Kuna K; Gohlke H; Kassack MU; Kurz T
J Med Chem; 2013 Jan; 56(2):427-36. PubMed ID: 23252603
[TBL] [Abstract][Full Text] [Related]
43. Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid.
Bieliauskas AV; Weerasinghe SV; Negmeldin AT; Pflum MK
Arch Pharm (Weinheim); 2016 May; 349(5):373-82. PubMed ID: 27062198
[TBL] [Abstract][Full Text] [Related]
44. Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.
Dorjsuren D; Eastman RT; Wicht KJ; Jansen D; Talley DC; Sigmon BA; Zakharov AV; Roncal N; Girvin AT; Antonova-Koch Y; Will PM; Shah P; Sun H; Klumpp-Thomas C; Mok S; Yeo T; Meister S; Marugan JJ; Ross LS; Xu X; Maloney DJ; Jadhav A; Mott BT; Sciotti RJ; Winzeler EA; Waters NC; Campbell RF; Huang W; Simeonov A; Fidock DA
Sci Rep; 2021 Jan; 11(1):2121. PubMed ID: 33483532
[TBL] [Abstract][Full Text] [Related]
45. Interrogating alkyl and arylalkylpolyamino (bis)urea and (bis)thiourea isosteres as potent antimalarial chemotypes against multiple lifecycle forms of Plasmodium falciparum parasites.
Verlinden BK; de Beer M; Pachaiyappan B; Besaans E; Andayi WA; Reader J; Niemand J; van Biljon R; Guy K; Egan T; Woster PM; Birkholtz LM
Bioorg Med Chem; 2015 Aug; 23(16):5131-43. PubMed ID: 25684422
[TBL] [Abstract][Full Text] [Related]
46. Flavones as isosteres of 4(1H)-quinolones: discovery of ligand efficient and dual stage antimalarial lead compounds.
Rodrigues T; Ressurreição AS; da Cruz FP; Albuquerque IS; Gut J; Carrasco MP; Gonçalves D; Guedes RC; dos Santos DJ; Mota MM; Rosenthal PJ; Moreira R; Prudêncio M; Lopes F
Eur J Med Chem; 2013 Nov; 69():872-80. PubMed ID: 24125849
[TBL] [Abstract][Full Text] [Related]
47. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.
Patil V; Guerrant W; Chen PC; Gryder B; Benicewicz DB; Khan SI; Tekwani BL; Oyelere AK
Bioorg Med Chem; 2010 Jan; 18(1):415-25. PubMed ID: 19914074
[TBL] [Abstract][Full Text] [Related]
48. Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activity.
Bailey BL; Nguyen W; Ngo A; Goodman CD; Gancheva MR; Favuzza P; Sanz LM; Gamo FJ; Lowes KN; McFadden GI; Wilson DW; Laleu B; Brand S; Jackson PF; Cowman AF; Sleebs BE
Bioorg Chem; 2021 Oct; 115():105244. PubMed ID: 34452759
[TBL] [Abstract][Full Text] [Related]
49. Cyclic Tetrapeptide HDAC Inhibitors with Improved
Collins JE; Lee JW; Bohmer MJ; Welden JD; Arshadi AK; Du L; Cichewicz RH; Chakrabarti D
ACS Infect Dis; 2021 Oct; 7(10):2889-2903. PubMed ID: 34491031
[TBL] [Abstract][Full Text] [Related]
50. Antiplasmodial dihetarylthioethers target the coenzyme A synthesis pathway in Plasmodium falciparum erythrocytic stages.
Weidner T; Lucantoni L; Nasereddin A; Preu L; Jones PG; Dzikowski R; Avery VM; Kunick C
Malar J; 2017 May; 16(1):192. PubMed ID: 28502250
[TBL] [Abstract][Full Text] [Related]
51. Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton.
Mwakwari SC; Guerrant W; Patil V; Khan SI; Tekwani BL; Gurard-Levin ZA; Mrksich M; Oyelere AK
J Med Chem; 2010 Aug; 53(16):6100-11. PubMed ID: 20669972
[TBL] [Abstract][Full Text] [Related]
52. Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide.
Canzoneri JC; Chen PC; Oyelere AK
Bioorg Med Chem Lett; 2009 Dec; 19(23):6588-90. PubMed ID: 19854643
[TBL] [Abstract][Full Text] [Related]
53. Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box.
Reader J; van der Watt ME; Taylor D; Le Manach C; Mittal N; Ottilie S; Theron A; Moyo P; Erlank E; Nardini L; Venter N; Lauterbach S; Bezuidenhout B; Horatscheck A; van Heerden A; Spillman NJ; Cowell AN; Connacher J; Opperman D; Orchard LM; Llinás M; Istvan ES; Goldberg DE; Boyle GA; Calvo D; Mancama D; Coetzer TL; Winzeler EA; Duffy J; Koekemoer LL; Basarab G; Chibale K; Birkholtz LM
Nat Commun; 2021 Jan; 12(1):269. PubMed ID: 33431834
[TBL] [Abstract][Full Text] [Related]
54. Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion.
Nguyen W; Dans MG; Ngo A; Gancheva MR; Romeo O; Duffy S; de Koning-Ward TF; Lowes KN; Sabroux HJ; Avery VM; Wilson DW; Gilson PR; Sleebs BE
Eur J Med Chem; 2021 Mar; 214():113253. PubMed ID: 33610028
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening.
Liu J; Zhou J; He F; Gao L; Wen Y; Gao L; Wang P; Kang D; Hu L
Eur J Med Chem; 2020 Apr; 192():112189. PubMed ID: 32151834
[TBL] [Abstract][Full Text] [Related]
56. Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle.
Le Manach C; Nchinda AT; Paquet T; Gonzàlez Cabrera D; Younis Y; Han Z; Bashyam S; Zabiulla M; Taylor D; Lawrence N; White KL; Charman SA; Waterson D; Witty MJ; Wittlin S; Botha ME; Nondaba SH; Reader J; Birkholtz LM; Jiménez-Díaz MB; Martínez MS; Ferrer S; Angulo-Barturen I; Meister S; Antonova-Koch Y; Winzeler EA; Street LJ; Chibale K
J Med Chem; 2016 Nov; 59(21):9890-9905. PubMed ID: 27748596
[TBL] [Abstract][Full Text] [Related]
57. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
[TBL] [Abstract][Full Text] [Related]
58. Chromobacterium spp. mediate their anti-Plasmodium activity through secretion of the histone deacetylase inhibitor romidepsin.
Saraiva RG; Huitt-Roehl CR; Tripathi A; Cheng YQ; Bosch J; Townsend CA; Dimopoulos G
Sci Rep; 2018 Apr; 8(1):6176. PubMed ID: 29670144
[TBL] [Abstract][Full Text] [Related]
59. Lactam based 7-amino suberoylamide hydroxamic acids as potent HDAC inhibitors.
Taddei M; Cini E; Giannotti L; Giannini G; Battistuzzi G; Vignola D; Vesci L; Cabri W
Bioorg Med Chem Lett; 2014 Jan; 24(1):61-4. PubMed ID: 24345446
[TBL] [Abstract][Full Text] [Related]
60. In vitro inhibition of Plasmodium falciparum early and late stage gametocyte viability by extracts from eight traditionally used South African plant species.
Moyo P; Botha ME; Nondaba S; Niemand J; Maharaj VJ; Eloff JN; Louw AI; Birkholtz L
J Ethnopharmacol; 2016 Jun; 185():235-42. PubMed ID: 26994818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
